[Analysis of results of drug therapy for symptomatic multiple myeloma].
| Autor: | Lysenko LB, Nikolaeva N, Pushkareva TF, Kapuza EA, Shatokhina ON, Kozyuk OV, Dmitrieva VV, Snezhko TA, Novoselova KA |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Voprosy onkologii [Vopr Onkol] 2015; Vol. 61 (4), pp. 667-70. |
| Abstrakt: | Drug therapy for symptomatic multiple myeloma is comparable for both sexes in its effectiveness and safety. A 3-year event-free survival is comparable in men and women; overall survival in men is lower than in women. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|